Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: outcome and economic analysis of the GERSHWIN study

被引:0
|
作者
Willich, S. N.
Brueggenjuergen, B.
Mcbride, D.
Bode, C.
Hamm, C. W.
Kuck, K. -H.
机构
[1] Charite Univ Med Berlin, Med Ctr, Inst Sozialmed & Epidemiol, Berlin, Germany
[2] Univ Hosp Freiburg, Freiburg, Germany
[3] Kerckhoff Klin, Bad Nauheim, Germany
[4] Ctr Heart, LBK, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:769 / 769
页数:1
相关论文
共 50 条
  • [1] Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: Outcome and economic analysis of the GERSHWIN study
    Willich, Stefan N.
    Bruggenjurgen, Bernd
    McBride, Doreen
    Bode, Christoph
    Hamm, Christian
    Kuck, Karl-Heinz
    CIRCULATION, 2006, 114 (18) : 689 - 689
  • [2] Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: Outcome and economic analysis of the GERSHWIN study
    Willich, Stefan N.
    Bruggenjurgen, Bernd
    McBride, Doreen
    Bode, Christoph
    Hamm, Christian W.
    Kuck, Karl-Heinz
    CIRCULATION, 2006, 113 (21) : E794 - E794
  • [3] Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: outcome and economic analysis of the GERSHWIN Study
    Willich, S. N.
    Brueggenjuergen, B.
    Mcbride, D.
    Bode, C.
    Hamm, C. W.
    Kuck, K. H.
    EUROPEAN HEART JOURNAL, 2007, 28 : 508 - 508
  • [4] Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis:: Outcome and economic analysis of the GERSHWIN Study
    Willich, Stefan N.
    Brueggenjuergen, Bernd
    McBride, Doreen
    Bode, Christoph
    Christian, Hamm
    Kuck, Karl-Heinz
    CIRCULATION, 2007, 116 (16) : 470 - 470
  • [5] Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 3-year clinical outcome and economic analysis of the GERSHWIN study
    Willich, S.
    Brueggenjuergen, B.
    Mcbride, D.
    Bode, C.
    Hamm, C.
    Kuck, K. H.
    EUROPEAN HEART JOURNAL, 2009, 30 : 89 - 90
  • [6] Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis -: 18-month angiographic results from the GERSHWIN study
    Brueggenjuergen, Bernd
    McBride, Doreen
    Bode, Christoph
    Hamm, Christian W.
    Kuck, Karl-Heinz
    Willich, Stefan N.
    HERZ, 2007, 32 (08) : 650 - 655
  • [7] Sirolimus-eluting versus bare-metal coronary stents:: 18-month clinical and economic outcomes of a controlled study for the reduction of coronary restenosis
    McBride, D.
    Brueggenjuergen, B.
    Roll, S.
    Willich, S. N.
    VALUE IN HEALTH, 2007, 10 (06) : A237 - A237
  • [8] Drug-eluting versus bare-metal stents for the reduction of coronary restenosis: outcome and economic analysis of a controlled study
    Willich, S. N.
    Brueggenjuergen, B.
    McBride, D.
    Bode, C.
    Hamm, C. W.
    Kuck, K. -H.
    EUROPEAN HEART JOURNAL, 2005, 26 : 709 - 709
  • [9] Drug-eluting versus bare-metal coronary stents:: Outcome analysis of a controlled study for the reduction of coronary restenosis
    McBride, D
    Brüggenjürgen, BB
    Willich, SN
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (11) : S28 - S28
  • [10] Effect of sirolimus-eluting stents versus bare-metal stents on outcomes related to restenosis and disease progression in remote coronary segments
    Chacko, Riya S.
    Novack, Victor
    Mulhearn, Meredith
    Novack, Lena
    Popma, Jeffrey J.
    Mauri, Laura
    Cohen, Sidney A.
    Moses, Jeffrey
    Leon, Martin B.
    Cutlip, Donald E.
    CIRCULATION, 2007, 116 (16) : 469 - 469